CTOR vs RL · $105.2M cap vs P/E 24, rev $7.08B
Citius Oncology, Inc. (CTOR) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported RL revenue for 2025-03-29 was $7.08B. Net income was $742.9M. Revenue was up 6.7% from 2024-03-30 to 2025-03-29. RL currently screens at market cap $16.95B and trailing P/E 24.1.
CTOR currently screens at market cap $105.2M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the CTOR and RL stock pages for the full models.
Not investment advice.